In another investigation, the patients with anti-GBM disease who had low levels of serum C3 had a higher proportion of glomerular sclerosis progressing to kidney failure compared to the patients with normal levels; in addition, the serum C3 level at diagnosis was an independent protective factor for kidney outcomes of anti-GBM disease [166]. Here, C3 is linked to glomerulosclerosis.